Gastro-Intestinal Committee

Aims & Scope

The Gastrointestinal Committee strives to:

  • Assist in the planning of the annual meeting scientific program and the review of submitted abstracts in the field of digestive diseases
  • Review the status of CGT and regenerative medicine for digestive diseases and foster international discussion about controversies in this field
  • Publish position papers and engage scientific discourse as necessary to advance the field
  • Increase the awareness of CGT and regenerative medicine for digestive diseases, mostly in young investigators

Featured Video

The American Society of Transplantation (AST) and the Tissue Engineering and Regenerative Medicine International Society (TERMIS) are coming together to launch a new webinar series called:

Joining Forces to Shape Our Mutual Future

The immediate short-term goal of the webinars is to establish a collaboration between the two societies, who are leaders in their respective fields of transplants and regenerative medicine.
The medium-term goal of the webinars is to prepare the ground to a new conference series, the World Conferences of Transplant and Regenerative Medicine that will be launched once we will have left the COVID pandemic behind us.
The long-term goal of the webinars (and of the new conference series) is to bring together experts from both fields on the same stage for the first time, in order to share knowledge and ultimately foster progress in organ bioengineering, regeneration and repair which will shape and define the future of both worlds.
The webinars will be held quarterly and will consist of a 1-hour session, featuring two speakers, one proposed by each society. In 2021, access to webinars will not be restricted in order to stimulate interest and promote the event beyond the two societies.
Our ISCT GI Committee endorses this AST and TERMIS endeavor and embraces this vision.

Letter from the ISCT Gastrointestinal Committee

Dr. Rachele Ciccocioppo and Dr. Giuseppe Orlando have penned a letter, on the behalf of the ISCT Gastrointestinal Committee, to further encourage the inclusion of cell and gene therapy discussions and education in the gastrointestinal field in light of recent developments. ISCT members are kindly asked to please share this letter with their colleagues in the gastrointestinal field.

View the letter.

Report of the last European Crohn’s & Colitis Organisation Congress: growing attention on organoids as disease modelling in inflammatory bowel disease.

One of the ISCT Gastrointestinal Committee's main objectives is to increase awareness of cell and gene therapies in the field of the digestive system, and to promote the safe and effective use of these medicinal therapies worldwide. To help achieve these goals, the Committee conducts regular literature reviews, selects novel research to be featured alongside critical analyses developed by Committee members, and drafts reports on important events in the field.

View the report.

ISCT Position on Diversity and Inclusiveness

International Society for Cell & Gene Therapy Releases Position Statement on Diversity and Inclusiveness. View the full statement.

ISCT, alongside ASTCT, CIBMTR, EBMT, and FACT, issue a joint statement against racism. View the joint statement.

The Committee

Headshot of Rachele Ciccocioppo


Rachele Ciccocioppo, MD
January 2018 - Present

University of Verona
Verona, Italy

Headshot of Giuseppe Orlando


Giuseppe Orlando, MD, PhD
January 2018 - Present

Wake Forest University
Winston-Salem, United States


Mattia Algeri, MD
Ospedale Pediatrico Bambino Gesù
Rome, Italy

Daniel C. Baumgart, MD, PhD, MBA, FRCP
University of Alberta
Edmonton, Canada

Vincenzo Cardinale, MD, PhD
Sapienza University of Rome
Rome, Italy

Gianluca Carnevale, PhD
University of Modena and Reggio Emilia
Modena, Italy
ESP Leadership Development Program

Paolo De Coppi, MD, PhD
National Institute for Health Research
London, United Kingdom

Claudia Dos Santos, MD, MSc
University of Toronto
Toronto, Canada

Damián García-Olmo, MD, PhD
Jiménez Díaz Foundation University Hospital
Madrid, Spain

Eleuterio Lombardo, PhD
Takeda Madrid, Cell Therapy Technology Center
Madrid, Spain

Basak Uygun, PhD
Harvard Medical School
Boston, United States

Hongjun Wang, PhD
Medical University of South Carolina
Charleston, United States